BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27017167)

  • 1. Value of E-PASS models for predicting postoperative morbidity and mortality in resection of perihilar cholangiocarcinoma and gallbladder carcinoma.
    Haga Y; Miyamoto A; Wada Y; Takami Y; Takeuchi H
    HPB (Oxford); 2016 Mar; 18(3):271-8. PubMed ID: 27017167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Validation of the Estimation of Physiologic Ability and Surgical Stress (E-PASS) Risk Model to Predict Operative Risk in Perihilar Cholangiocarcinoma.
    Coelen RJ; Olthof PB; van Dieren S; Besselink MG; Busch OR; van Gulik TM
    JAMA Surg; 2016 Dec; 151(12):1132-1138. PubMed ID: 27579510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the U.S. Extrahepatic Biliary Malignancy Consortium.
    Beal EW; Lyon E; Kearney J; Wei L; Ethun CG; Black SM; Dillhoff M; Salem A; Weber SM; Tran TB; Poultsides G; Shenoy R; Hatzaras I; Krasnick B; Fields RC; Buttner S; Scoggins CR; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Pawlik TM; Schmidt CR
    HPB (Oxford); 2017 Dec; 19(12):1104-1111. PubMed ID: 28890310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.
    Dekker AM; Wiggers JK; Coelen RJ; van Golen RF; Besselink MG; Busch OR; Verheij J; Hollmann MW; van Gulik TM
    HPB (Oxford); 2016 Mar; 18(3):262-70. PubMed ID: 27017166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Olthof PB; Coelen RJS; Bennink RJ; Heger M; Lam MF; Besselink MG; Busch OR; van Lienden KP; van Gulik TM
    HPB (Oxford); 2017 Oct; 19(10):850-858. PubMed ID: 28687148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile duct surgery in the treatment of hepatobiliary and gallbladder malignancies: effects of hepatic and vascular resection on outcomes.
    Shen P; Fino N; Levine EA; Eversole P; Clark C
    HPB (Oxford); 2015 Dec; 17(12):1066-73. PubMed ID: 26373784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant.
    Wiggers JK; Groot Koerkamp B; Cieslak KP; Doussot A; van Klaveren D; Allen PJ; Besselink MG; Busch OR; D'Angelica MI; DeMatteo RP; Gouma DJ; Kingham TP; van Gulik TM; Jarnagin WR
    J Am Coll Surg; 2016 Aug; 223(2):321-331.e1. PubMed ID: 27063572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of general surgical risk models for predicting postoperative liver failure and mortality following liver surgery.
    Haga Y; Ikejiri K; Takeuchi H; Ikenaga M; Wada Y
    J Surg Oncol; 2012 Dec; 106(7):898-904. PubMed ID: 22605669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.
    Noji T; Tsuchikawa T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Shichinohe T; Hirano S
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):442-8. PubMed ID: 27207604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External biliary drainage following major liver resection for perihilar cholangiocarcinoma: impact on development of liver failure and biliary leakage.
    Olthof PB; Coelen RJ; Wiggers JK; Besselink MG; Busch OR; van Gulik TM
    HPB (Oxford); 2016 Apr; 18(4):348-53. PubMed ID: 27037204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative computed tomography assessment of skeletal muscle mass is valuable in predicting outcomes following hepatectomy for perihilar cholangiocarcinoma.
    Coelen RJ; Wiggers JK; Nio CY; Besselink MG; Busch OR; Gouma DJ; van Gulik TM
    HPB (Oxford); 2015 Jun; 17(6):520-8. PubMed ID: 25726722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major hepatectomies for perihilar cholangiocarcinoma: Predictors for clinically relevant postoperative complications using the International Study Group of Liver Surgery definitions.
    Dumitrascu T; Brasoveanu V; Stroescu C; Ionescu M; Popescu I
    Asian J Surg; 2016 Apr; 39(2):81-9. PubMed ID: 26103932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
    Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive power of prothrombin time and serum total bilirubin for postoperative mortality after major hepatectomy with extrahepatic bile duct resection.
    Yokoyama Y; Ebata T; Igami T; Sugawara G; Ando M; Nagino M
    Surgery; 2014 Mar; 155(3):504-11. PubMed ID: 24287146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: A propensity score matching analysis of resectable perihilar cholangiocarcinoma.
    Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    Surgery; 2017 Feb; 161(2):394-404. PubMed ID: 27712872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the POSSUM, P-POSSUM and E-PASS scores in the surgical treatment of hilar cholangiocarcinoma.
    Wang H; Wang H; Chen T; Liang X; Song Y; Wang J
    World J Surg Oncol; 2014 Jun; 12():191. PubMed ID: 24961847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors.
    Kimura N; Young AL; Toyoki Y; Wyatt JI; Toogood GJ; Hidalgo E; Prasad KR; Kudo D; Ishido K; Hakamada K; Lodge JPA
    Surgery; 2017 Sep; 162(3):500-514. PubMed ID: 28551378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal indications for additional resection of the invasive cancer-positive proximal bile duct margin in cases of advanced perihilar cholangiocarcinoma.
    Oguro S; Esaki M; Kishi Y; Nara S; Shimada K; Ojima H; Kosuge T
    Ann Surg Oncol; 2015; 22(6):1915-24. PubMed ID: 25404474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of general surgical risk models for predicting postoperative morbidity and mortality in pancreatic resections for pancreatobiliary carcinomas.
    Haga Y; Wada Y; Saitoh T; Takeuchi H; Ikejiri K; Ikenaga M
    J Hepatobiliary Pancreat Sci; 2014 Aug; 21(8):599-606. PubMed ID: 24648305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.